<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-989</article-id>
      <article-id pub-id-type="doi">10.51847/ouHxjrpdl7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>UV Spectroscopic Method Development and Validation of Rabeprazole and Levosulpiride in its Bulk and Dosage Form</article-title>
      </title-group>
                  <pub-date pub-type="epub">
        <day>28</day>
        <month>12</month>
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>5</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Logical strategy is the heart of drug investigation. The current work endeavored to foster precise, straightforward, and delicate techniques for concurrent assessment of rabeprazole and levosulpiride. The overlay range of levosulpiride and rabeprazole display λmax of 288 nm and 282 nm for LEVO and RABE. Standard adjustment bends for levosulpiride and rabeprazole were straight with connection coefficient (r) values in the scope of 0.9998-0.9997 at all chosen frequencies. The precision of the technique was affirmed by recuperation contemplated from the tablet at three distinct degrees of 80%, 100 percent, and 120% recuperation in the scope of 99.97-100 percent legitimizes the exactness of the strategy. Intraday and Interday accuracy was checked for UV strategy, and % RSD was viewed as under 2 for UV technique. The created strategy is a fast device for routine examination of rabeprazole and levosulpiride in the mass and the drug dose structure. Considering the possible general improvement of phony medication portions, the proposed strategy could be important for the quality control research offices in developing countries. </p>
      </abstract>
      <kwd-group>
              </kwd-group>
    </article-meta>
  </front>
</article>